Evotec completes Just.Bio acquisition
Evotec SE has completed its acquisition of Just Biotherapeutics (Just.Bio). Evotec says the deal will strengthen its multimodality approach to R&D. Evotec acquired Just.Bio to integrate its machine-learning technologies and agile, flexible methods for the design, development, and manufacturing of biologics into Evotec’s drug discovery offerings. Just.Bio’s 95 employees and
